Table 5 Probability of residual neuromuscular blockade according to the neuromuscular blocking agent, neuromuscular monitoring and pharmacological reversal according to the generalized linear model.
NMB agent | Intraoperative NMM | Pharmacological reversal | Probability RNMB (%) |
|---|---|---|---|
Cisatracurium | No | No | 40.5 |
Rocuronium | No | No | 41.2 |
Cisatracurium | Yes | No | 14.2 |
Rocuronium | Yes | No | 14.6 |
Cisatracurium | No | Neostigmine | 39.5 |
Rocuronium | No | Sugammadex | 8.33 |
Cisatracurium | Yes | Neostigmine | 13.7 |
Rocuronium | Yes | Sugammadex | 2.17 |
